Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial
可切除黑色素瘤新辅助治疗中，PD-1 和 LAG-3 靶向双特异性抗体与其他免疫检查点抑制剂联合疗法：一项随机 1b/2 期 Morpheus-Melanoma 试验
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-03967-2
Long, Georgina V; Nair, Nitya; Marbach, Daniel; Scolyer, Richard A; Wilson, Sabine; Cotting, Denise; Staedler, Nicolas; Amaria, Rodabe N; Ascierto, Paolo Antonio; Tarhini, Ahmad A; Robert, Caroline; Hamid, Omid; Gaudy-Marqueste, Caroline; Lebbe, Celeste; Munoz-Couselo, Eva; Menzies, Alexander M; Pages, Cecile; Curigliano, Giuseppe; Mandala, Mario; Jessop, Nikki; Bader, Uwe; Perdicchio, Maurizio; Teichgräber, Volker; Muecke, Merlind; Markert, Christoph; Blank, Christian
